PLIANT THERAPEUTICS, INC. (PLRX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, PLIANT THERAPEUTICS, INC. reported revenue of $0. The company ran a net loss. It held $225.23M in total assets against $44.02M in total liabilities.
Key ratios (FY2025)
-82.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1.58M | $9.69M | $7.57M | $41.82M | $57.05M | — |
| Operating Income | -$156.37M | -$228.37M | -$184.15M | -$127.20M | -$97.53M | -$41.65M | -$1.23M | — |
| Net Income | -$149.34M | -$210.30M | -$161.34M | -$123.32M | -$97.26M | -$41.53M | -$631.0K | — |
| EPS (Diluted) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | — |
| Total Assets | $225.23M | $396.95M | $512.15M | $350.61M | $221.22M | $295.53M | $119.06M | — |
| Total Liabilities | $44.02M | $92.87M | $38.58M | $37.27M | $22.16M | $12.46M | $9.08M | — |
| Shareholders' Equity | $181.21M | $304.08M | $473.58M | $313.34M | $199.06M | $283.06M | -$76.30M | -$71.47M |
| Cash & Equivalents | $45.45M | $71.19M | $63.23M | $33.69M | $51.66M | $50.88M | $85.81M | — |
| Operating Cash Flow | -$128.34M | -$155.50M | -$116.36M | -$94.63M | -$75.44M | -$37.27M | -$2.75M | — |
| Capital Expenditures | $374.0K | $3.85M | $921.0K | $1.76M | $1.95M | $1.53M | $964.0K | — |
| Shares Outstanding | 61.45M | 60.86M | 59.92M | 48.94M | 36.08M | 35.55M | 1.85M | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |